SCHEMBL21114368

SCHEMBL21114368

NC(CCSSCCC(N)C(=O)O)C(=O)O.NC(CCSSCCC(N)C(=O)O)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BHMT Q93088 8/20 0.57
▸ BHMT2 Q9H2M3 1/20 0.55
▸ NOS2 P35228 2/20 0.55
▸ NOS3 P29474 1/20 0.55
▸ NOS1 P29475 1/20 0.55
▸ GSR P00390 2/20 0.54
▸ GRM8 O00222 1/20 0.54
▸ GRM6 O15303 1/20 0.54
▸ GRIN2D O15399 1/20 0.54
▸ GRIN3B O60391 1/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ GRIK1 P39086 1/20 0.54
▸ GRM5 P41594 1/20 0.54
▸ GRIA1 P42261 1/20 0.54
▸ GRIA2 P42262 1/20 0.54
▸ GRIA3 P42263 1/20 0.54
▸ SLC1A3 P43003 1/20 0.54
▸ SLC1A2 P43004 1/20 0.54
▸ SLC1A1 P43005 1/20 0.54
▸ GRIA4 P48058 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31268050 1.00 BHMT (0.57) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL14242026 1.00 BHMT (0.57) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL224295 1.00 BHMT (0.57) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL385396 1.00 BHMT (0.57) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL385397 1.00 BHMT (0.57) BHMTBHMT2NOS2NOS3NOS1
Hydrogen Sulfide SCHEMBL27649836 0.97 BHMT (0.55) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL31443066 0.97 BHMT (0.55) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL30448407 0.97 BHMT (0.55) BHMTBHMT2NOS2NOS3NOS1
Potassium SCHEMBL31443073 0.97 BHMT (0.55) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL27616884 0.97 BHMT (0.55) BHMTBHMT2NOS2NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190214145-A1 Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen KUREK ITZHAK (US) 2019-07-11 — — US disclosed
Send feedback